Continuous Control of Tracheal Cuff Pressure and Microaspiration in Critically Ill Patients

NCT ID: NCT01082666

Last Updated: 2015-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

122 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-10-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We hypothesized that continuous control of tracheal cuff pressure would reduce microaspiration of gastric content as determined by pepsin level in tracheal aspirate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Randomized controlled open label study, performed in a 10-bed ICU. All patients intubated with a PVC-cuffed tracheal tube and receiving enteral nutrition who require at least 48 h of mechanical ventilation are eligible. Patients receive continuous control of cuff pressure using a pneumatic device (intervention group) or manual control using a manometer (control group). Target cuff pressure is 25 cmH2O.

In all patients, pepsin is measured in tracheal aspirate during a 48-h period after inclusion, as proxy for gastric content aspiration. In addition tracheobronchial colonization and ventilator associated pneumonia rates will be compared between the two groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critically Ill

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Continuous control

Continuous control of cuff pressure using a pneumatic device

Group Type EXPERIMENTAL

Continuous control of cuff pressure

Intervention Type DEVICE

Continuous control of cuff pressure using a pneumatic device (Nosten, Leved, France)

Manual control

Manual control of cuff pressure is a routine practice in ICU patients

Group Type ACTIVE_COMPARATOR

Manual control of cuff pressure

Intervention Type DEVICE

Manual control of cuff pressure is a routine practice in ICU patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous control of cuff pressure

Continuous control of cuff pressure using a pneumatic device (Nosten, Leved, France)

Intervention Type DEVICE

Manual control of cuff pressure

Manual control of cuff pressure is a routine practice in ICU patients

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Automatic control of cuff pressure (Rusch, Kernen, Germany) Manual manometer

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \> or = 18 years
* tracheal intubation using a polyvinylchloride tube
* predictible duration of mechanical ventilation \> 48 h
* enteral nutrition

Exclusion Criteria

* refuse to participate to the study
* no informed consent
* contra-indication for semirecumbment position
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alain Durocher, MD

Role: STUDY_DIRECTOR

CHRU de Lille

Malika Balduyck, MD

Role: STUDY_DIRECTOR

CHU de Lille

Farid Zerimech, MD

Role: STUDY_DIRECTOR

CHU de Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ICU, Calmette Hospital, University Hospital of Lille

Lille, Nord, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009-A00431-56

Identifier Type: OTHER

Identifier Source: secondary_id

2008_53/0919

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TRacheal Cuff PRessure Evaluation Study
NCT06848010 NOT_YET_RECRUITING NA